Back to Search Start Over

Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma

Authors :
Kyotaro Fukuta
Keito Shiozaki
Saki Kobayashi
Ryoichi Nakanishi
Hirofumi Izaki
Kazuya Kanda
Tohru Inai
Eiji Kudo
Tomoya Fukawa
Kunihisa Yamaguchi
Yasuyo Yamamoto
Masayuki Takahashi
Hiro-omi Kanayama
Source :
Case Reports in Oncology, Vol 15, Iss 1, Pp 369-375 (2022)
Publication Year :
2022
Publisher :
Karger Publishers, 2022.

Abstract

A 72-year-old man visited our hospital due to pollakiuria and lower abdominal pain. Urinary cytology was positive, and cystoscopy revealed diffuse edematous nonpapillary tumor. We performed transurethral biopsy, and clinical stage T3 plasmacytoid variant of urothelial carcinoma (PUC) was diagnosed. Although we planned for radical cystectomy, peritoneal dissemination and lung and pelvic lymph node metastases appeared 3 weeks after the initial visit. We also planned for chemotherapy; however, the metastases rapidly progressed, and he died 7 weeks after the biopsy. PUC is rare and shows an aggressive clinical course and poor prognosis.

Details

Language :
English
ISSN :
16626575
Volume :
15
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Case Reports in Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.50aa4ba2af4940858457af5fdd01a7b5
Document Type :
article
Full Text :
https://doi.org/10.1159/000524038